← Back to Clinical Trials
Recruiting NCT07449195

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

Trial Parameters

Condition Ocular Tumor
Sponsor Memorial Sloan Kettering Cancer Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-02-27
Completion 2028-02-27
Interventions
Intalight Dream OCTHeidelberg Spectralis OCT

Brief Summary

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years. * At least 1 eye that has an intraocular or ocular surface tumor. * The presence of a natural crystalline lens or intraocular lens. * Pupils that can dilate up to at least 3 mm in the study eyes. * The absence of opaque natural crystalline lenses or the presence of any ocular disease that prevents the view of the retina for imaging. * Patients must be able to fixate on the imaging target. * Patients must be able to sit still for a period of time (approximately 2 minutes). Exclusion Criteria: * Does not meet ALL of the above conditions

Related Trials